Cipla said it received approval for its HIV treatment combination medicine 'TLD' from the South African Health Products Regulatory Authority (SAHPRA). The drug will be manufactured at Cipla's facilities in Durban and Uganda. The announcement was made after market hours yesterday, 11 S...read more